These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 8993839

  • 1. Fenretinide: induction of apoptosis and endogenous transforming growth factor beta in PC-3 prostate cancer cells.
    Roberson KM, Penland SN, Padilla GM, Selvan RS, Kim CS, Fine RL, Robertson CN.
    Cell Growth Differ; 1997 Jan; 8(1):101-11. PubMed ID: 8993839
    [Abstract] [Full Text] [Related]

  • 2. N-(4-hydroxyphenyl)retinamide activation of transforming growth factor-beta and induction of apoptosis in human breast cancer cells.
    Herbert BS, Sanders BG, Kline K.
    Nutr Cancer; 1999 Jan; 34(2):121-32. PubMed ID: 10578478
    [Abstract] [Full Text] [Related]

  • 3. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y, Kyprianou N.
    Cancer Res; 1999 Mar 15; 59(6):1366-71. PubMed ID: 10096572
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y, Kyprianou N.
    Cell Growth Differ; 1998 Feb 15; 9(2):185-93. PubMed ID: 9486855
    [Abstract] [Full Text] [Related]

  • 6. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N.
    Prostate; 2008 Feb 15; 68(3):287-95. PubMed ID: 18163430
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells.
    Appierto V, Villani MG, Cavadini E, Gariboldi M, De Cecco L, Pierotti MA, Lambert JR, Reid J, Tiberio P, Colombo N, Formelli F.
    Oncogene; 2007 Jun 07; 26(27):3952-62. PubMed ID: 17213814
    [Abstract] [Full Text] [Related]

  • 9. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F, Lee J, Lu S, Pettaway CA, Dong Z.
    Clin Cancer Res; 2005 Jun 15; 11(12):4512-20. PubMed ID: 15958637
    [Abstract] [Full Text] [Related]

  • 10. Cell death induced by N-(4-hydroxyphenyl)retinamide in human epidermal keratinocytes is modulated by TGF-beta and diminishes during the progression of squamous cell carcinoma.
    Davies M, Paterson IC, Ganapathy A, Prime SS.
    Int J Cancer; 2006 Dec 15; 119(12):2803-11. PubMed ID: 17044020
    [Abstract] [Full Text] [Related]

  • 11. Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators.
    Batra S, Reynolds CP, Maurer BJ.
    Cancer Res; 2004 Aug 01; 64(15):5415-24. PubMed ID: 15289350
    [Abstract] [Full Text] [Related]

  • 12. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid.
    Delia D, Aiello A, Lombardi L, Pelicci PG, Grignani F, Grignani F, Formelli F, Menard S, Costa A, Veronesi U.
    Cancer Res; 1993 Dec 15; 53(24):6036-41. PubMed ID: 8261419
    [Abstract] [Full Text] [Related]

  • 13. N-(4-Hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cells.
    Simeone AM, Colella S, Krahe R, Johnson MM, Mora E, Tari AM.
    Carcinogenesis; 2006 Mar 15; 27(3):568-77. PubMed ID: 16199439
    [Abstract] [Full Text] [Related]

  • 14. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells.
    Tang B, de Castro K, Barnes HE, Parks WT, Stewart L, Böttinger EP, Danielpour D, Wakefield LM.
    Cancer Res; 1999 Oct 01; 59(19):4834-42. PubMed ID: 10519393
    [Abstract] [Full Text] [Related]

  • 15. Hypoxia-mediated fenretinide (4-HPR) resistance in childhood acute lymphoblastic leukemia cells.
    Yang B, Fan L, Fang L, He Q.
    Cancer Chemother Pharmacol; 2006 Oct 01; 58(4):540-6. PubMed ID: 16520989
    [Abstract] [Full Text] [Related]

  • 16. Transforming growth factor-beta 1 induces apoptosis in gastric cancer cells through a p53-independent pathway.
    Yamamoto M, Maehara Y, Sakaguchi Y, Kusumoto T, Ichiyoshi Y, Sugimachi K.
    Cancer; 1996 Apr 15; 77(8 Suppl):1628-33. PubMed ID: 8608554
    [Abstract] [Full Text] [Related]

  • 17. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G, Schwarz RE, Higgins L, McEnroe G, Chakravarty S, Dugar S, Reiss M.
    Cancer Res; 2004 Aug 01; 64(15):5200-11. PubMed ID: 15289325
    [Abstract] [Full Text] [Related]

  • 18. The anticancer agent prodigiosin induces p21WAF1/CIP1 expression via transforming growth factor-beta receptor pathway.
    Soto-Cerrato V, Viñals F, Lambert JR, Pérez-Tomás R.
    Biochem Pharmacol; 2007 Nov 01; 74(9):1340-9. PubMed ID: 17765876
    [Abstract] [Full Text] [Related]

  • 19. In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer.
    Brewer M, Wharton JT, Wang J, McWatters A, Auersperg N, Gershenson D, Bast R, Zou C.
    Gynecol Oncol; 2005 Aug 01; 98(2):182-92. PubMed ID: 15907982
    [Abstract] [Full Text] [Related]

  • 20. Induction of rat liver parenchymal cell apoptosis by hepatic myofibroblasts via transforming growth factor beta.
    Gressner AM, Polzar B, Lahme B, Mannherz HG.
    Hepatology; 1996 Mar 01; 23(3):571-81. PubMed ID: 8617439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.